ClinicalTrials.Veeva

Menu

Post-operative Electrical Muscle Stimulation to Stimulate Muscle Protein Synthesis in Humans (PoEMS)

U

University of Nottingham

Status

Active, not recruiting

Conditions

Skeletal Muscle Atrophy

Treatments

Other: Neuromuscular electrical stimulation (NMES/0

Study type

Interventional

Funder types

Other

Identifiers

NCT05997095
FMHS 261-0423

Details and patient eligibility

About

Skeletal muscle accounts for approximately 45-55% of total body mass in healthy adults and plays a pivotal role in whole-body metabolic health, locomotion and physical independence. Undesirable loss of skeletal muscle mass (atrophy) is, however, a common feature of many communicable and non-communicable diseases including ageing, bed-rest/immobilisation, cancer and physical inactivity. As such, the design of optimal strategies (e.g., different types of exercise) to "offset" these detrimental losses of muscle is a focus for both researchers and clinicians.

One situation where losses of muscle mass occur very quickly (i.e., within a few days) is after surgery. However, at this time, most people (especially if they have had major abdominal or lower-limb surgery) are not able to perform exercise and as such a different strategy to maintain muscle mass needs to be found. It has been shown that electrical stimulation of the leg muscles can maintain muscle mass and function in patients after surgery. It is not however yet known, what the optimal electrical stimulation regime is to preserve muscle mass during situations of disuse.

This study aims to examine the impact of three different electrical stimulation protocols on muscle building processes in individuals age-matched to those most commonly presenting for major abdominal surgery. This information will then be used in a clinical trial of surgical patients to see if it can preserve their muscle mass and function in the post-operative period.

Full description

The contraction of skeletal muscles depends on the regulation of the nervous system and the coordination of neuromuscular function. The smallest motor nervous system associated with muscle contraction is the motor unit (MU), which consists of an efferent motor neuron and all of the muscle fibres it innervates. Muscle tissue also undergoes adaptive alternations in response to external stimuli, such as the gradual decline in muscle mass and strength during ageing, and atrophy following muscle disuse. A number of studies have demonstrated that different types of voluntary movements, such as resistance exercise training (RET), can prevent or attenuate such alternations to a certain extent via increases in muscle protein synthesis (MPS).

However, certain situations such as post-operative bed rest render RET interventions an unachievable option. Neuromuscular electrical stimulation (NMES) can be applied as a surrogate; acting to evoke involuntary contraction of the target muscles via electrical current applied to the muscle belly. Although NMES stimulation has been widely tested in the intensive care environment, results have shown variable efficacy- perhaps due to the multi-organ failure and associated catabolic systemic environment encountered by the majority of these patients.

It has recently shown that in post-operative abdominal surgery patients, 5-days of NMES, performed at frequency of 30 Hz in a 1 second "on", 1 second "off" contraction pattern, can mitigate losses in muscle mass and function. However, this study 'borrowed' a protocol from previous intensive care literature, and as such may not be optimal with regards to frequency or contraction pattern. Given that this protocol was highly tolerated by patients in a previous study (i.e., based on 30 min of daily NMES, patients in this study said they would tolerate it for 45 to 240 (mean 90) min), it is plausible that higher frequency NMES (~100 Hz), enabling greater force production may be both viable and result in further mitigation of muscle mass and function losses. It has also been demonstrated that the time muscle is under loaded tension during RET may be an important modulator of MPS and subsequent gains in muscle mass. Therefore, increasing the contraction relative to relaxation time during NMES (e.g., 3 seconds on, 1 second off) may be another feasible and perhaps more beneficial strategy to reduce muscle mass losses in populations where an increase in frequency may not be possible or tolerable.

Knowing that muscle maintenance is based on a dynamic equilibrium between MPS and muscle protein breakdown, the impact of different NMES protocols on MPS, associated cell signalling, and nutrient delivery pathways needs to be explored so that an optimal intervention can be tested in clinical settings associated with disuse atrophy. To date, no previous studies have compared differing frequencies of NMES on the muscle metabolic responses in older adults, nor the effect of differing NMES-induced contraction patterns.

Enrollment

10 patients

Sex

All

Ages

60 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 60-85 y
  • Willing and able to give informed consent for participation in the study

Exclusion criteria

  • BMI <18.5 or >35kg/m2
  • Participation in any regular, structured RET within the past 6 months
  • Musculoskeletal disorders
  • Severe respiratory disease:
  • COPD
  • Pulmonary hypertension
  • Neurological disorders:
  • Cerebrovascular disease (cerebral haemorrhage; cerebral ischemic stroke)
  • Intracranial space-occupying lesion
  • Epilepsy
  • Metabolic disease:
  • Hyper and hypo parathyroidism
  • Untreated hyper and hypothyroidism
  • Cushing's disease
  • Type 1 or 2 diabetes
  • Active cardiovascular problems:
  • Uncontrolled hypertension (BP>160/100mmHg)
  • Recent cardiac event
  • Heart failure (Class III/IV)
  • Arrhythmia
  • Angina
  • Blood clotting disorders
  • Active inflammatory bowel or renal disease
  • Recent malignancy (in previous 3 years)
  • Recent steroid treatment within 6 months or hormone replacement therapy
  • Family history of early (<55yrs) death from cardiovascular disease
  • Known sensitivity to Sonovue

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

10 participants in 3 patient groups

30Hz (low-intensity)
Active Comparator group
Description:
Volunteers receive 30 mins of neuromuscular electrical stimulation at 30Hz with a contraction pattern of 1 second "on" and 1 second "off"
Treatment:
Other: Neuromuscular electrical stimulation (NMES/0
100Hz (higher-intensity)
Experimental group
Description:
Volunteers receive 30 mins of neuromuscular electrical stimulation at 100Hz with a contraction pattern of 1 second "on" and 1 second "off"
Treatment:
Other: Neuromuscular electrical stimulation (NMES/0
30Hz (low-intensity, 3:1)
Experimental group
Description:
Volunteers receive 30 mins of neuromuscular electrical stimulation at 30Hz with a contraction pattern of 3 seconds "on" and 1 second "off"
Treatment:
Other: Neuromuscular electrical stimulation (NMES/0

Trial contacts and locations

1

Loading...

Central trial contact

Bethan Phillips, PhD; Mathew Piasecki, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems